Related Experiment Video

Updated: Jul 8, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.2K

Effect of intelligent hypertension management system on blood pressure: protocol for a randomised controlled

Haiyang Yu1, Xiang Chen2, Jiachun Xia2

  • 1Department of cardiology, Shanghai Songjiang District Central Hospital, Songjiang, Shanghai, China.

BMJ Open
|December 12, 2023
PubMed

Insights

This study evaluated an Intelligent Hypertension Management System (IHMS) for hypertension control. The IHMS aims to help patients self-monitor blood pressure at home, potentially improving hypertension management.

Area of Science:

  • Cardiovascular Medicine
  • Health Informatics
  • Digital Health

Background:

  • Hypertension is a major global health concern with suboptimal control rates in China.
  • Lifestyle interventions and medication are primary treatments, but new strategies are needed.
  • Self-monitoring of blood pressure offers a promising approach for improved hypertension management.

Purpose of the Study:

  • To investigate the effectiveness of the Intelligent Hypertension Management System (IHMS) in reducing blood pressure among hypertensive patients.
  • To assess if IHMS facilitates intelligent hypertension management through remote monitoring and guidance.

Main Methods:

  • A multi-center, prospective, randomized controlled study involving 320 eligible subjects.
  • Participants were randomized into an IHMS management group (n=160) and a conventional care group (n=160).
  • The primary outcome was the net change in systolic blood pressure after 3 months, analyzed using a mixed-effects model.

Main Results:

  • The study aims to determine if the IHMS group exhibits a greater reduction in systolic blood pressure compared to the conventional care group.
  • Analysis will focus on the primary outcome measure at the 3-month follow-up.
  • The mixed-effects model will be employed for robust statistical comparison.

Conclusions:

  • The findings will elucidate the efficacy of the IHMS in improving blood pressure control.
  • Results will inform the potential integration of digital health platforms in hypertension management strategies.
  • Dissemination of findings is planned through publications and conference presentations.
Abstract

Keywords:
Blood PressureClinical TrialHypertension

More Related Videos

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

753
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K

Related Concept Videos

Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
733
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
1.1K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
632
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
648